within Pharmacolibrary.Drugs.ATC.N;

model N03AX11
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 1.7e-05,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0007,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.005166666666666667,
    Tlag           = 10.200000000000001
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N03AX11</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Topiramate is an anticonvulsant medication primarily used in the treatment of epilepsy and the prevention of migraines. It is approved and widely used today for partial-onset or primary generalized tonic-clonic seizures in adults and children, as well as for migraine prophylaxis.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters from healthy adult subjects following oral administration. Mostly studied in both male and female individuals aged 18-55 years with normal renal function.</p><h4>References</h4><ol><li><p>Graham, LT, et al., &amp; Li, Z (2023). The pharmacokinetics of single oral dose extended-release topiramate and adverse effects after multi-dose administration in healthy cats. <i>Journal of veterinary pharmacology and therapeutics</i> 46(4) 218–228. DOI:<a href=\"https://doi.org/10.1111/jvp.13121\">10.1111/jvp.13121</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36872425/\">https://pubmed.ncbi.nlm.nih.gov/36872425</a></p></li><li><p>Zaccara, G, &amp; Perucca, E (2014). Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs. <i>Epileptic disorders : international epilepsy journal with videotape</i> 16(4) 409–431. DOI:<a href=\"https://doi.org/10.1684/epd.2014.0714\">10.1684/epd.2014.0714</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25515681/\">https://pubmed.ncbi.nlm.nih.gov/25515681</a></p></li><li><p>Schneiderman, JH (1998). Topiramate: pharmacokinetics and pharmacodynamics. <i>The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques</i> 25(3) S3–S5. DOI:<a href=\"https://doi.org/10.1017/s031716710003482x\">10.1017/s031716710003482x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9706732/\">https://pubmed.ncbi.nlm.nih.gov/9706732</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N03AX11;
